IL6 and neoplasm: Studies undertaken with IL-6 transgenic mice and colon-26 tumor-bearing mice that display elevated plasma IL-6 levels have demonstrated about 25 % decrease in gastrocnemius muscle weight (Zhou et al. 2003).